DAVIDE CAMPARI-MILANO NV (CPR.MI) Fundamental Analysis & Valuation

BIT:CPR • NL0015435975

Current stock price

6.228 EUR
-0.05 (-0.86%)
Last:

This CPR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CPR.MI Profitability Analysis

1.1 Basic Checks

  • In the past year CPR was profitable.
  • In the past year CPR had a positive cash flow from operations.
  • CPR had positive earnings in each of the past 5 years.
  • In the past 5 years CPR always reported a positive cash flow from operatings.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.27%, CPR is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
  • CPR's Return On Equity of 8.97% is in line compared to the rest of the industry. CPR outperforms 50.00% of its industry peers.
  • With a decent Return On Invested Capital value of 6.57%, CPR is doing good in the industry, outperforming 63.33% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 7.47%.
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROIC 6.57%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • CPR has a better Profit Margin (11.35%) than 70.00% of its industry peers.
  • In the last couple of years the Profit Margin of CPR has remained more or less at the same level.
  • With a decent Operating Margin value of 19.74%, CPR is doing good in the industry, outperforming 70.00% of the companies in the same industry.
  • CPR's Operating Margin has improved in the last couple of years.
  • CPR has a better Gross Margin (60.31%) than 86.67% of its industry peers.
  • CPR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. CPR.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CPR is creating some value.
  • CPR has less shares outstanding than it did 1 year ago.
  • CPR has more shares outstanding than it did 5 years ago.
  • CPR has a better debt/assets ratio than last year.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • CPR has an Altman-Z score of 2.66. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.66, CPR is doing good in the industry, outperforming 76.67% of the companies in the same industry.
  • CPR has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as CPR would need 6.60 years to pay back of all of its debts.
  • CPR's Debt to FCF ratio of 6.60 is fine compared to the rest of the industry. CPR outperforms 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.59 indicates that CPR is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.59, CPR is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Altman-Z 2.66
ROIC/WACC0.99
WACC6.6%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.22 indicates that CPR has no problem at all paying its short term obligations.
  • The Current ratio of CPR (2.22) is better than 80.00% of its industry peers.
  • CPR has a Quick Ratio of 2.22. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.96, CPR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 0.96
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

5

3. CPR.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.22% over the past year.
  • The Earnings Per Share has been growing by 12.04% on average over the past years. This is quite good.
  • The Revenue has decreased by -0.60% in the past year.
  • Measured over the past years, CPR shows a quite strong growth in Revenue. The Revenue has been growing by 11.48% on average per year.
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%

3.2 Future

  • Based on estimates for the next years, CPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.76% on average per year.
  • Based on estimates for the next years, CPR will show a small growth in Revenue. The Revenue will grow by 3.30% on average per year.
EPS Next Y4.41%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
EPS Next 5Y18.76%
Revenue Next Year0.52%
Revenue Next 2Y2.5%
Revenue Next 3Y3.34%
Revenue Next 5Y3.3%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0 0 0 0
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

3

4. CPR.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • CPR is valuated rather expensively with a Price/Earnings ratio of 21.48.
  • Compared to the rest of the industry, the Price/Earnings ratio of CPR is on the same level as its industry peers.
  • CPR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.42.
  • The Price/Forward Earnings ratio is 19.76, which indicates a rather expensive current valuation of CPR.
  • CPR's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of CPR to the average of the S&P500 Index (22.24), we can say CPR is valued inline with the index average.
Industry RankSector Rank
PE 21.48
Fwd PE 19.76
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CPR's Enterprise Value to EBITDA ratio is in line with the industry average.
  • CPR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 19.75
EV/EBITDA 12.75
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPR does not grow enough to justify the current Price/Earnings ratio.
  • CPR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.87
PEG (5Y)1.78
EPS Next 2Y8.37%
EPS Next 3Y9.02%

3

5. CPR.MI Dividend Analysis

5.1 Amount

  • CPR has a Yearly Dividend Yield of 1.52%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.74, CPR is paying slightly less dividend.
  • Compared to an average S&P500 Dividend Yield of 1.81, CPR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.52%

5.2 History

  • The dividend of CPR decreases each year by -0.23%.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • CPR pays out 22.52% of its income as dividend. This is a sustainable payout ratio.
DP22.52%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

CPR.MI Fundamentals: All Metrics, Ratios and Statistics

DAVIDE CAMPARI-MILANO NV

BIT:CPR (4/24/2026, 7:00:00 PM)

6.228

-0.05 (-0.86%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)03-04
Earnings (Next)05-06
Inst Owners21.27%
Inst Owner ChangeN/A
Ins Owners50.82%
Ins Owner ChangeN/A
Market Cap7.67B
Revenue(TTM)3.05B
Net Income(TTM)346.30M
Analysts73.33
Price Target7.3 (17.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.52%
Yearly Dividend0.04
Dividend Growth(5Y)-0.23%
DP22.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.81%
PT rev (3m)3.66%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.73%
EPS NY rev (3m)-3.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.77%
Revenue NY rev (3m)-2.12%
Valuation
Industry RankSector Rank
PE 21.48
Fwd PE 19.76
P/S 2.51
P/FCF 19.75
P/OCF 11.15
P/B 1.99
P/tB 19.33
EV/EBITDA 12.75
EPS(TTM)0.29
EY4.66%
EPS(NY)0.32
Fwd EY5.06%
FCF(TTM)0.32
FCFY5.06%
OCF(TTM)0.56
OCFY8.97%
SpS2.48
BVpS3.14
TBVpS0.32
PEG (NY)4.87
PEG (5Y)1.78
Graham Number4.52368 (-27.37%)
Profitability
Industry RankSector Rank
ROA 4.27%
ROE 8.97%
ROCE 8.89%
ROIC 6.57%
ROICexc 7.34%
ROICexgc 17.16%
OM 19.74%
PM (TTM) 11.35%
GM 60.31%
FCFM 12.73%
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
ROICexc(3y)7.81%
ROICexc(5y)8.35%
ROICexgc(3y)19.64%
ROICexgc(5y)24.18%
ROCE(3y)9.45%
ROCE(5y)9.92%
ROICexgc growth 3Y-14.23%
ROICexgc growth 5Y-7.25%
ROICexc growth 3Y-6.36%
ROICexc growth 5Y1.27%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
F-Score8
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 6.6
Debt/EBITDA 3.02
Cap/Depr 201.82%
Cap/Sales 9.81%
Interest Coverage 6.43
Cash Conversion 91.62%
Profit Quality 112.13%
Current Ratio 2.22
Quick Ratio 0.96
Altman-Z 2.66
F-Score8
WACC6.6%
ROIC/WACC0.99
Cap/Depr(3y)282.75%
Cap/Depr(5y)284.75%
Cap/Sales(3y)11.87%
Cap/Sales(5y)11.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
EPS Next Y4.41%
EPS Next 2Y8.37%
EPS Next 3Y9.02%
EPS Next 5Y18.76%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
Revenue Next Year0.52%
Revenue Next 2Y2.5%
Revenue Next 3Y3.34%
Revenue Next 5Y3.3%
EBIT growth 1Y1.65%
EBIT growth 3Y2.34%
EBIT growth 5Y14.68%
EBIT Next Year24.97%
EBIT Next 3Y12.76%
EBIT Next 5Y19.58%
FCF growth 1Y84.55%
FCF growth 3Y149.17%
FCF growth 5Y15.69%
OCF growth 1Y2.55%
OCF growth 3Y21.81%
OCF growth 5Y20.37%

DAVIDE CAMPARI-MILANO NV / CPR.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?

ChartMill assigns a fundamental rating of 5 / 10 to CPR.MI.


What is the valuation status for CPR stock?

ChartMill assigns a valuation rating of 3 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.


How profitable is DAVIDE CAMPARI-MILANO NV (CPR.MI) stock?

DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 7 / 10.


What is the valuation of DAVIDE CAMPARI-MILANO NV based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DAVIDE CAMPARI-MILANO NV (CPR.MI) is 21.48 and the Price/Book (PB) ratio is 1.99.


Can you provide the expected EPS growth for CPR stock?

The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 4.41% in the next year.